Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 3, 1996, Pages 300-309

  Maeda, Atsuko ^b   Sobel, Raymond A ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Astrocytes; Endothelial cells; Extracellular matrix; Macrophages; Matrix metalloproteinases; Microglia; Multiple sclerosis

Indexed keywords

COLLAGENASE; GELATINASE; GELATINASE B; STROMELYSIN;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DEMYELINATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LEUKOCYTE MIGRATION; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0029867128     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199603000-00005     Document Type: Article

References (65)

1. Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:21450-54
2. Kleiner DE Jr, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteases. Curr Op Cell Biol 1993;5: 891-97
3. Welgus HG, Senior RM, Parks WC, Kahn AJ, Ley TJ, Shapiro SD, Campbell EJ. Neutral proteinase expression by human mononuclear phagocytes: A prominent role of cellular differentiation. Matrix 1992;Suppl. 1:363-67
4. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 1993;296:803-9
5. Sciavolino PJ, Lee TH, Vilcek J. Interferon-β induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1. J Biol Chem 1994;269:21627-34
6. Xie B, Dong Z, Fidler IJ. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages J Immunol 1994;52:3637-44
7. Busiek DF, Baragi V, Nehring LC, Parks WC, Welgus HG. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol 1995;154:6484-91
8. Stefansson S, Aimes RT, Seward NB, Alexander DS, Quigley JR Native TIMP-free 70 kDa progelatinase (MMP-2) secreted at elevated levels by RSV transformed fibroblasts. J Cell Physiol 1994;161:419-28
9. Dhawan S, Weeks BS, Soderland C, et al. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol 1995;154:422-32
10. Tremble P, Chiquet-Ehrismann R, Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Molec Biol of the Cell 1994;5: 439-53
11. Seltzer JL, Lee A-Y, Akers KT, Sudbeck B, Southon EA, Wayner EA, Eisen AZ. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res 1994;213:365-74
12. Clark EA, Brugge JS. Integrins and signal transduction pathways: The road taken. Science 1995;268:233-39
13. Suzuki K, Lees M, Newlands GFJ, Nagase H, Woolley DE. Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. Biochem J 1995;305:301-6
14. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 1986;261:2814-18
15. Leppart D, Waubant E, Galardy R, Bunnett NW, Hauser SL. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-89
16. Greenwald RA, Golub LM, eds, Inhibition of matrix metalloproteinases: Therapeutic potential. Ann NY Acad Sci 1994;732:1-507
17. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995;9:974-80
18. Sobel RA, Schneeberger EE, Colvin RB. The immunopathology of acute experimental allergic encephalomyelitis: V. A light microscopic and ultrastructural immunohistochemical analysis of fibronectin and fibrinogen. Am J Pathol 1988;131:547-58
19. Sobel RA, Mitchell ME. Fibronectin in multiple sclerosis lesions. Am J Pathol 1989;135:161-69
20. Esiri MM, Morris CS. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 2. Non-neoplastic diseases. J Neurol Sci 1991;101: 59-72
21. Chen M, Maeda A, Sobel RA. Laminin (Ln) and endothelial cell (EC) integrin Ln receptors in multiple sclerosis (MS) lesions. (Abstract) J Neuroimmunol 1994;54:198
22. Rutka JT, Apodaca G, Stern R, Rosenblum M. The extracellular matrix of the central and peripheral nervous system: Structure and function. J Neurosurg 1988;69:155-70
23. Asher RA, Scheibe RJ, Keiser HD, Bignami A. On the existence of a cartilage-link proteoglycan and link proteins in the central nervous system. Glia 1995;13:294-308
24. Cserr HF, Harling-Berg CJ, Knopf PM. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathology 1992;2:269-76
25. Bignami A, LeBlanc A, Perides G. A role for extracellular matrix degradation and matrix metalloproteinases in senile dementia? Acta Neuropathol 1994;87:308-12
26. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994;81:69-77
27. Romanic AM, Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 1994;4:145-56
28. Peress N, Perillo E, Zucker S. Localization of tissue inhibitor of matrix metalloproteinases in Alzheimcr's disease and normal brain. J Neuropathol Exp Ncurol 1995;54:16-22
29. Apodaca G, Rutka J, Bouhana K, Berens ME, Giblin JR, Rosenbhim ML, McKerrow JH, Banda MJ. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 1990;50:2322-29
30. Gottschall PE, Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 1995;64:1513-20
31. Sobel RA. The pathology of multiple sclerosis. In: Antel J, ed. Symposium on multiple sclerosis. Neurol Clin North America 1995;13:1-21
32. Einstein ER, Csejtey J, Dalal KB, Adams CWM, Bayliss OB, Hallpike JF. Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: Combined biochemical and histochemical observations. J Neurochem 1972;19:653-62
33. Cammer W, Bloom BR, Norton WT, Gordon S. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination. Proc Natl Acad Sci USA 1978;75:1554-58
34. Hirsch HE. Proteinases and demyelination. J Histochem Cytochem 1981;29:425-30
35. Allen IV. Hydrolytic enzymes in multiple sclerosis. In: Zimmerman HM, ed. Progress in neuropathology. New York: Raven Press, 1983, 5:1-17
36. Banik NL. Pathogenesis of myelin breakdown in demyelinating diseases: Role of proteolytic enzymes. Crit Rev Neurobiol 1992;6: 257-71
37. Brosnan CF, Cammer W, Norton WT, Bloom BR. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature 1980;285:235-37
38. Smith ME. Proteinase inhibitors and the suppression of EAE. In: Davison AN, Cuzner ML, eds. The suppression of experimental allergic encephalomyelitis and multiple sclerosis. London: Academic Press, 1980:211-26
39. Gijbels K, Galardy RE, Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 1994;94:2177-82
40. Ulvestad E, Williams K, Mørk S, Antel J, Nyland H. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J Neuropathol Exp Neurol 1994;53:492-501
41. Gijbels K, Steinman L. Gelatinase B producing cells in multiple sclerosis lesions. (Abstract). J Cell Biochem Suppl 1994;18D:143
42. Colton CA, Keri JE, Chen W-T, Monsky WL. Protease production by cultured microglia: Substrate gel analysis and immobilized matrix degradation. J Neurosci Res 1993;35:297-304
43. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res 1994;38:365-75
44. Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CE Biology of disease - microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 1991,64:135-56
45. Gehrmann J, Kreutzberg GW. Monoclonal antibodies against macrophages/microglia: Immunocytochemical studies of early microglial activation in experimental neuropathology. Clin Neuropathol 1993;12:301-6
46. Bö L, Mörk S, Kong PA, Nyland H, Pardo CA, Trapp BA. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994;51:135-46
47. Sobel RA, Chen M, Maeda A, Hinojoza JR. Vitronectin and integrin Vitronectin receptor localization in multiple sclerosis lesions. J Neuropathol Exp Neurol 1995;54:202-13
48. Nakajima K, Kohsaka S. Functional roles of microglia in the brain. Neuroscience Res 1993;17:187-203
49. Mönning U, Sandbrink R, Weidemann A, Banati RB, Masters CL, Beyreuther K. Extracellular matrix influences the biogenesis of amyloid precursor protein in microglial cells. J Biol Chem 1995;270: 7104-10
50. Chamak B, Mallat M. Fibronectin and laminin regulate the in vitro differentiation of microglial cells. Neuroscience 1991;45:513-27
51. Rosenberg GA, Dencoff IE, McGuirc PG, Liotta L, Stetler-Stevenson WG. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab Invest 1994;71:417-22
52. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170: 607-12
53. Woodroofe MN, Cuzner ML. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridization. Cytokine 1993;5:583-88
54. Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995;45(Suppl 6):S16-21
55. Gearing AJH, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 1994;370:555-61
56. Zajicek JP, Wing M, Scolding NJ, Compston DAS. Interactions between oligodendrocytes and microglia - a major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain 1992;115:1611-31
57. Proost P, Van Damme J. Opdenakker G. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem Biophys Res Comm 1993;192:1175-81
58. Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein, (submitted)
59. Lehmann PV, Sercarz EE, Fosthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993;14:203-8
60. Eddelston M, Mucke L. Commentary - molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 1993;54:15-36
61. Kwon EE, Prineas JW. Blood-brain barrier abnormalities in long-standing multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol 1994;53:625-36
62. Yim SH, Sherin JE, Szuchet S. Oligodendrocyte proteoglycans: Modulation by cell-substratum adhesion. J Neurosci Res 1993;34: 401-13
63. Muir D, Manthorpe M. Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation. J Cell Biol 1992;116: 177-85
64. Muir D. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exptl Cell Res 1994;210:243-52
65. Backstrom JR, Tökés ZA. The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. J Neurochem 1995;64:1312-18